TY  - GEN
AU  - Skedgel,Chris
AU  - Rayson,Daniel
AU  - Younis,Tallal
TI  - Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?
SN  - 1433-7339
PY  - 2016///0801
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Chemotherapy-Induced Febrile Neutropenia
KW  - economics
KW  - Cost-Benefit Analysis
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Decision Support Techniques
KW  - Docetaxel
KW  - Female
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Middle Aged
KW  - Primary Prevention
KW  - Quality-Adjusted Life Years
KW  - Risk Factors
KW  - Taxoids
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00520-015-2805-7
ER  -